|
Q3 2019
Filed on Nov 12, 2019
|
74,689
|
$95.8 - $118.9
$7.16M - $8.88M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
498,733
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
741,969
|
$8.02 - $13.25
$5.95M - $9.83M
|
|
Alder Biopharmaceuticals Inc
|
Q3 2019
Filed on Nov 12, 2019
|
233,858
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
411,503
|
N/A
|
|
Adamas Pharmaceuticals Inc
|
Q3 2019
Filed on Nov 12, 2019
|
223,959
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
6,769,297
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
30,000,000
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
75,050,000
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
7,985
|
$134.24 - $148.53
$1.07M - $1.19M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
48,920
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
669,245
|
$4.86 - $6.05
$3.25M - $4.05M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
118,323
|
$83.82 - $101.5
$9.92M - $12M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
7,600
|
N/A
|
|
Marinus Pharmaceuticals Inc
|
Q3 2019
Filed on Nov 12, 2019
|
284,860
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
131,573
|
$12.44 - $17.48
$1.64M - $2.3M
|
|
Macquarie Infrastructure Cor
|
Q3 2019
Filed on Nov 12, 2019
|
100,000
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
439,853
|
$8.59 - $10.96
$3.78M - $4.82M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
418,296
|
$1.03 - $1.75
$431K - $732K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
119,310
|
$72.82 - $86.52
$8.69M - $10.3M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
250,433
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
3,470
|
$56.41 - $67.29
$196K - $233K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
306,686
|
$1.25 - $2.35
$383K - $721K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
128,637
|
$6.47 - $8.96
$832K - $1.15M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
16,180,848
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
221,297
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
38,438
|
$2.12 - $9.37
$81.5K - $360K
|
|
Stemline Therapeutics Inc
|
Q3 2019
Filed on Nov 12, 2019
|
212,936
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
32,000
|
$27.99 - $34.39
$896K - $1.1M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
61,652
|
$32.4 - $49.58
$2M - $3.06M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
86,596
|
$9.01 - $12.55
$780K - $1.09M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
95,246
|
$7.03 - $9.7
$670K - $924K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
22,000
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
188,982
|
$1.5 - $2.99
$283K - $565K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
438,330
|
$1.6 - $2.08
$701K - $912K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
40,720
|
$18.62 - $24.51
$758K - $998K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
56,837
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
185,899
|
$16.51 - $23.78
$3.07M - $4.42M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
60,683
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
273,947
|
$7.77 - $11.26
$2.13M - $3.08M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
3,500
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
83,000
|
$42.77 - $50.71
$3.55M - $4.21M
|
|
Actinium Pharmaceuticals Inc
|
Q3 2019
Filed on Nov 12, 2019
|
596,752
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
10,000
|
$26.75 - $31.73
$268K - $317K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
45,700
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
25,837
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
666,589
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
266,877
|
$15.02 - $21.51
$4.01M - $5.74M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
194,991
|
$8.22 - $11.2
$1.6M - $2.18M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
69,203
|
$6.55 - $8.6
$453K - $595K
|
|